Stock Markets March 9, 2026

Moscow equities climb as energy, telecoms and industrials lead gains

MOEX Russia Index posts 1.17% rise to a three-month high; mixed commodity moves accompany the session

By Jordan Park ROSN
Moscow equities climb as energy, telecoms and industrials lead gains
ROSN

Russia's benchmark MOEX Russia Index closed higher on Monday, rising 1.17% to a new three-month high as the Oil & Gas, Telecoms and Manufacturing sectors provided upward momentum. Market breadth was mixed, with slightly more decliners than advancers, while commodity prices and currency pairs showed divergent moves during the session.

Key Points

  • MOEX Russia Index rose 1.17% to a reported three-month high, led by Oil & Gas, Telecoms and Manufacturing sectors.
  • Top individual gainers included AFK Sistema (+3.39%), Rosneft (+3.04%) and OZON (+1.78%); laggards included OK Rusal (-3.03%) and Surgutneftegas shares (-2.24% and -1.76%).
  • Commodities were mixed: April Gold futures fell 0.19% to $5,148.65 per troy ounce, April Crude dropped 6.40% to $85.08 a barrel, while May Brent rose 1.02% to $89.91.

Russia's stock market ended the trading day in positive territory on Monday, with the MOEX Russia Index advancing 1.17% to reach what the exchange recorded as a three-month high.

Gains were concentrated in several key sectors, notably Oil & Gas, Telecoms and Manufacturing, which together supported the broader index move.

On an issue-by-issue basis, AFK Sistema PJSC (MCX:AFKS) was the session's top performer on the MOEX Russia Index, adding 3.39% - a 0.45 point increase - to close at 13.70. Rosneft PJSC (MCX:ROSN) also posted a strong advance, rising 3.04% or 14.20 points to finish at 481.70. Online retailer OZON (MCX:OZON) traded up 1.78%, a gain of 80.50 points, closing the session at 4,602.00.

Not all names moved higher: OK Rusal MKPAO (MCX:RUAL) ended the day on the back foot, falling 3.03% or 1.35 points to 43.06. Surgutneftegas PJSC (MCX:SNGS) declined 2.24% or 0.52 points to 22.72, while Surgutneftegas PJSC Pref (MCX:SNGS_p) slipped 1.76% or 0.84 points to 46.85.

Market breadth on the Moscow Stock Exchange was mixed. Declining issues outnumbered advancing ones by 127 to 115, with 11 stocks finishing unchanged.


The Russian Volatility Index - RVI, which measures the implied volatility of options on the MOEX Russia Index, eased 0.16% to 24.68 during the session.

Commodities traded mixed alongside equity moves. Gold Futures for April delivery were reported down 0.19% or 10.05 to $5,148.65 a troy ounce. In energy markets, Crude oil for April delivery fell sharply, down 6.40% or 5.82 to reach $85.08 a barrel. By contrast, the May Brent oil contract recorded a gain of 1.02% or 0.91, trading at $89.91 a barrel.

Currency pairs involving the ruble were stable in the session: USD/RUB was unchanged at 79.47 and EUR/RUB was unchanged at 91.01. Meanwhile, the US Dollar Index Futures moved lower, down 0.25% to 98.74.


Overall, the session combined sector-led equity advances with mixed signals from commodities and modest shifts in implied volatility, producing a market environment in which headline index gains coexisted with a notable number of decliners.

Risks

  • Market breadth was mixed with more decliners (127) than advancers (115), indicating uneven participation across stocks - this primarily impacts equity investors and sector-specific strategies.
  • Significant daily movement in crude oil prices (April crude down 6.40%) introduces commodity-price volatility risk for Oil & Gas sector exposures.
  • Although the RVI eased slightly (-0.16% to 24.68), changes in implied volatility may signal shifting option-market sentiment that could affect risk management and derivative strategies.

More from Stock Markets

Fire Erupts After Major Explosion at Valero Refinery in Port Arthur, Texas Mar 23, 2026 US Futures Slip After Iran Denies Talks With Washington, Clouding De-escalation Hopes Mar 23, 2026 OpenAI Flags Microsoft Dependence and TSMC Risks in Investor Prospectus Mar 23, 2026 NTSB to Question Controller After LaGuardia Collision as Probe Expands Mar 23, 2026 Gilead Agrees to Acquire Ouro Medicines for Up to $2.2 Billion, Partners with Galapagos on Development Mar 23, 2026